Evidence check: AMH in the context of blood sugar

AMH (Anti-Müllerian Hormone) is a well-established marker of ovarian reserve, but its relationship with blood sugar is less clear. Current evidence is mostly mechanistic and associative, not causal. Some cross-sectional studies suggest an inverse association between AMH and fasting glucose or insulin resistance in reproductive-age women, especially those with PCOS. However, effect sizes are small, findings are inconsistent, and directionality remains uncertain. AMH is not used clinically for glycemic assessment. MyBody-X includes AMH in its hormone blood test, but interpreting it in the context of blood sugar is speculative without longitudinal or interventional data. A single AMH value does not justify dietary or lifestyle changes. For reliable blood sugar evaluation, established markers like HbA1c, fasting glucose, and OGTT should be used. Evidence grade: unclear. Sources: none from the provided context.